Ethamivan

CAS No. 304-84-7

Ethamivan( Analepticon, Etamivan, Ethamivan | NSC 406087 | NSC-406087 | NSC406087, Vandid )

Catalog No. M13965 CAS No. 304-84-7

Etamivan (INN) or ethamivan (USAN), trade name Analepticon, is a respiratory stimulant drug related to nikethamide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ethamivan
  • Note
    Research use only, not for human use.
  • Brief Description
    Etamivan (INN) or ethamivan (USAN), trade name Analepticon, is a respiratory stimulant drug related to nikethamide.
  • Description
    Etamivan (INN) or ethamivan (USAN), trade name Analepticon, is a respiratory stimulant drug related to nikethamide.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Analepticon, Etamivan, Ethamivan | NSC 406087 | NSC-406087 | NSC406087, Vandid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    304-84-7
  • Formula Weight
    223.27
  • Molecular Formula
    C12H17NO3
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 12.4 mg/mL
  • SMILES
    O=C(N(CC)CC)C1=CC=C(O)C(OC)=C1
  • Chemical Name
    Benzamide, N,N-diethyl-4-hydroxy-3-methoxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hirsh K, Wang SC. J Pharmacol Exp Ther. 1975 May; 193(2):657-63.
molnova catalog
related products
  • Rubinaphthin A

    Rubinaphthin A is a natural product from Rubia cordifolia.

  • Cyclosporin A-Deriva...

    Cyclosporin A-Derivative 1 (Free base) is a crystalline intermediate derived from the opening of cyclosporin A extracted from patent WO 2013167703 A1.

  • Atractylenolide III

    Atractylenolide III may have therapeutic potential in treating homocysteine-mediated cognitive impairment and neuronal injury.